Animal Model Market Report
Published Date: 22 April 2026 | Report Code: animal-model
Animal Model Market Size, Share, Industry Trends and Forecast to 2033
This report provides comprehensive insights into the Animal Model market, covering market size, growth trends, and detailed analyses from 2023 to 2033. Key data, industry dynamics, and forecasts will enable stakeholders to make informed decisions.
Key Takeaways
- Global market valued at $14.30 Billion in 2023, projected to reach $35.53 Billion by 2033.
- Projected compound annual growth rate of 9.2% across the 2023 to 2033 forecast period.
- North America is the largest region and is also the fastest-growing market during the forecast window.
- Oncology, neurology, immunology, and toxicology are primary applications supporting market demand.
- Leading companies include Charles River Laboratories, Janvier Labs, Envigo, and Taconic Biosciences.
Animal Model Market Report — Executive Summary
This report offers a concise assessment of the Animal Model market, documenting a $14.30 Billion valuation in 2023 and projected expansion to $35.53 Billion by 2033 at a 9.2% CAGR. Growth is driven by increased preclinical research, demand for disease-representative models, and investments from pharmaceutical companies, academic institutions, and contract research organizations. Technological developments in genetic engineering and model customization are reshaping product offerings and accelerating uptake across oncology, neurology, and immunology research. The competitive landscape features established suppliers such as Charles River Laboratories, Janvier Labs, Envigo, and Taconic Biosciences, while regional dynamics place North America as both the largest and the fastest-growing market. The report structure addresses market sizing, segmentation by type, species, end user, and application, and provides regional breakdowns and supplier profiles to guide strategic decisions.
Key Growth Drivers
- Rising preclinical activity from pharmaceutical companies and CROs that increases demand for validated animal models.
- Advances in genetic engineering enabling more disease-relevant and translatable models for therapeutic research.
- Regulatory emphasis on robust safety and efficacy testing that sustains need for standardized animal studies.
- Expanding academic research programs and collaborative projects that require specialized species and model types.
- Investment by key suppliers to broaden model portfolios and service capabilities, supporting market expansion.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $14.30 Billion |
| CAGR (2023-2033) | 9.2% |
| 2033 Market Size | $35.53 Billion |
| Top Companies | Charles River Laboratories, Janvier Labs, Envigo, Taconic Biosciences |
| Last Modified Date | 22 April 2026 |
Animal Model Market Overview
Customize Animal Model Market Report market research report
- ✔ Get in-depth analysis of Animal Model market size, growth, and forecasts.
- ✔ Understand Animal Model's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Animal Model
What is the Market Size & CAGR of Animal Model Market Report market in 2023?
Animal Model Industry Analysis
Animal Model Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Animal Model Market Report Market Analysis Report by Region
Europe Animal Model Market Report:
Europe grows from $4.47 Billion in 2023 to $11.1 Billion in 2033. Regional expansion is driven by active academic research, regulatory frameworks that support rigorous preclinical programs, and adoption of advanced model types for translational studies.Asia Pacific Animal Model Market Report:
Asia Pacific moves from $3.08 Billion in 2023 to $7.65 Billion in 2033. Growth is supported by increasing research capacity, rising pharmaceutical R&D, and expanding CRO activities that demand diversified animal models and related services.North America Animal Model Market Report:
North America starts from $4.6 Billion in 2023 and is projected to grow to $11.42 Billion in 2033. As the largest and fastest-growing region, it benefits from concentrated industry participants, substantial R&D investment, and strong demand from pharmaceutical companies and CROs.South America Animal Model Market Report:
Middle East & Africa Animal Model Market Report:
Middle East and Africa advance from $1.63 Billion in 2023 to $4.04 Billion in 2033. Growth drivers include expanding research initiatives, rising public and private funding for life-sciences, and developing laboratory capabilities to support preclinical testing.Tell us your focus area and get a customized research report.
Research Methodology
Animal Model Market Analysis By Species
In 2023, rodent models account for a significant market share of 86.28% amounting to $12.34 billion, expected to rise to $30.65 billion by 2033. Non-rodent models currently represent 13.72% of the market, valued at $1.96 billion, with a forecast of $4.87 billion in ten years. The high adoption rates for rodent models stem from their genetic mutability and physiological similarities to humans, making them favorable for preclinical testing.
Animal Model Market Analysis By Type
Genetically modified models led the market in 2023, holding a revenue share of 60.55% at approximately $8.66 billion. They are projected to reach $21.51 billion by 2033, fueled by advancements in genetic engineering. Wild-type models, with a 26.74% share translating to $3.82 billion, are projected to grow to $9.50 billion. Syndromic models represent a niche portion at 12.71%, starting at $1.82 billion in 2023 and expected to rise to $4.52 billion.
Animal Model Market Analysis By End User
Pharmaceutical companies dominate the Animal Model market with a significant share of 60.55%, amounting to $8.66 billion in 2023, forecasted to reach $21.51 billion by 2033. Academic institutions hold a 26.74% market share valued at $3.82 billion, projected to grow to $9.50 billion. CROs occupy the remaining 12.71% with $1.82 billion and are expected to reach $4.52 billion within the same timeframe.
Animal Model Market Analysis By Application
Oncology is the leading application area, holding a market share of 50.82% at $7.27 billion, escalating to $18.06 billion by 2033. Neurology follows with 24.54%, valued at $3.51 billion, projected to grow to $8.72 billion. Immunology stands at $1.67 billion (11.7% share) in 2023, aiming for $4.16 billion, while toxicology represents 12.94% of the market, starting at $1.85 billion and expected to reach $4.60 billion.
Animal Model Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Animal Model Industry
Charles River Laboratories:
A leading global provider of animal model services and products, Charles River Laboratories specializes in research models, preclinical testing, and drug development services.Janvier Labs:
Janvier Labs offers a variety of genetically modified and standard animal models for research, emphasizing the importance of robust animal welfare practices in compliance with regulations.Envigo:
Envigo provides integrated research services and reliable high-quality animal models, focusing on various applications such as pharmacology, toxicology, and general biology.Taconic Biosciences:
Taconic Biosciences is recognized for its expertise in breeding and supplying genetically engineered mouse models, catering primarily to the needs of the biopharmaceutical industry.We're grateful to work with incredible clients.
FAQs
What is the market size of the Animal Model Market Report in 2023?
The Animal Model market was valued at $14.30 Billion in 2023 and is forecast to expand to $35.53 Billion by 2033 at a 9.2% CAGR over 2023 to 2033.
How big is the projected market by 2033?
By 2033 the market is projected to reach $35.53 Billion, reflecting sustained expansion driven by research demand across pharmaceutical companies, academic institutions, and contract research organizations.
Why is North America significant in this market?
North America is the largest and fastest-growing region, supported by a $4.6 Billion base in 2023 growing to $11.42 Billion by 2033, with strong industry presence and investment.
Which companies lead the Animal Model market?
Leading vendors include Charles River Laboratories, Janvier Labs, Envigo, and Taconic Biosciences, providing animal models and related services to pharmaceutical firms, academic laboratories, and CROs.
Who are the primary end users in the market?
Primary end users are pharmaceutical companies, academic institutions, and contract research organizations, all referenced explicitly among the report's sub-segments, reflecting broad demand for preclinical models and testing platforms.
What is CAGR of the Animal Model Market Report?
The report specifies a compound annual growth rate of 9.2% for the market across the 2023 to 2033 forecast period, underpinning steady expansion in demand and investment.
How are regional markets expected to evolve?
Regional trajectories vary: Europe rises from $4.47 Billion to $11.1 Billion, Asia Pacific from $3.08 Billion to $7.65 Billion, and Middle East and Africa from $1.63 Billion to $4.04 Billion.
What factors drive demand for animal models?
Demand is driven by the need for disease-specific models, advances in genetic engineering, regulatory requirements for preclinical testing, and investments by biopharma, academic centers, and CROs.
Which applications dominate market use?
Primary applications include oncology, neurology, immunology, and toxicology, each listed among report sub-segments, reflecting their central role in therapeutic research, safety evaluation, and translational studies.